期刊文献+

308nm准分子光联合0.03%他克莫司软膏治疗面部白癜风疗效观察 被引量:7

Efficacy of 308 nm excimer light combined with tacrolimus ointment 0.03% in the treatment of facial vitiligo
下载PDF
导出
摘要 目的探讨308 nm准分子光联合0.03%他克莫司软膏治疗面部白癜风疗效及安全性。方法选取面部白癜风患者129例,按就诊顺序分为3组,A组为试验组,43例患者采用308 nm准分子光联合0.03%他克莫司软膏治疗;B组为对照1组,43例患者单用308 nm准分子光治疗;C组为对照2组,43例患者单用0.03%他克莫司软膏外用治疗,疗程均为12周或治疗至皮损完全复色。结果 A组、B组、C组的显效率分别为73.80%、47.61%、17.07%,A组与B组和C组显效率比较,差异有统计学意义(P<0.05)。3组患者均未出现严重不良反应。结论 308 nm准分子光联合0.03%他克莫司软膏治疗面部白癜风疗效好、不良反应少,显效率明显高于单独治疗。 Objective To evaluate the efifcacy and safety of 308 nm excimer light combined with tacrolimus ointment 0.03%for facial vitiligo. Methods A total of 129 outpatients with facial vitiligo were randomly divided into three groups, each group included 43 cases. Group A as the treatment group, treated with 308 nm excimer light combined with tacrolimus ointment 0.03%;Group B and C as controls were respectively treated with 308 nm excimer light or tacrolimus ointment 0.03%. The study lasted for 12 weeks or finished until complete repigmentation of the lesions. Results The signiifcant efifciency of the group A, B and C was 73.80%, 47.61%and 17.07%respectively, there was signiifcant difference between the group A and the other two groups (P〈0.05). There was no serious adverse reaction occurred in all the patients. Conclusion For the treatment of facial vitiligo, the efifciency of 308 nm excimer light combined with tacrolimus ointment 0.03%is signiifcant higher than the monotherapy, meanwhile with fewer adverse reactions.
出处 《实用皮肤病学杂志》 2013年第6期343-345,共3页 Journal of Practical Dermatology
关键词 白癜风 面部 308 nm准分子光 他克莫司 Vitiligo, face. 308-nmexcimerlight: Tacrolimus
  • 相关文献

参考文献9

  • 1白癜风临床分型及疗效标准(2003年修订稿)[J].中华皮肤科杂志,2004,37(7):440-440. 被引量:801
  • 2Das PK, van den Wijngaard RM, Wankowicz-Kalinska A, et al.A symbiotic concept of autoimmunity and tumour immunity:lessons from vitiligo [J], Trends Immunol, 2001, 22(3):130-136.
  • 3Bianchi B, Campolmi P, Mavilia L, et al. Monochromaticexcimer light(308 nm): an immunohistochemical study ofcutaneous T cells and apoptosis-related molecules in psoriasis [J].J Eur Acad Dermatol Venereol, 2003, 17(4):408-413.
  • 4Leone G, Iacovelli P, Paro Vidolin A, et al. Monochromaticexcimerlight 308 nm in the treatment of vitiligo: a pilot study [J].J Eur Acad Dermatol Venereol, 2003, 17(5):531-537.
  • 5Casacci M, Thomas P, Pacifico A, et al. Comparisonbetween308nm monochromatic excimer light and narrowbandUVBphototherapy (311-313 nm) in the treatment of vitiligo -amulticentre controlled study [J]. J Eur Acad Dermatol Venereol,2007,21(7):956-963.
  • 6Kang HY, Choi YM. FK506 increases pigmentationandmigration of human melanocytes [J]. Br J Dermatol, 2006,155(5):1037-1040.
  • 7Tanghetti EA. Tacrolimus ointment 0.1 % producesrepigmentationin patients with vitiligo:resuIts of a prospectivepatient series [J].Cutis, 2003,71(2):158-162.
  • 8Silverberg NB, Lin P, Travis L, et al. Tacrolimus ointmentpromot-es repigmentation of vitiligo in children:a review of 57cases [J].J Am Acad Dermatol, 2004, 51(5):760-766.
  • 9Xu AE, Zhang DM, Wei XD, et al. Efficacy and safetyoftarcrolimus cream 0.1% in the treatment of vitiligo [J]. Int JDermatol, 2009, 48(1):86-90.

共引文献800

同被引文献88

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部